We are studying the effects of a new treatment combining finerenone with SGLT2 inhibitors for people with type 2 diabetes. The goal is to see if this combination improves heart and kidney health.
Health conditions and diseases that the clinical trial is designed to study and treat.
Type 2 Diabetes is a chronic condition that affects the way your body metabolizes sugar (glucose), leading to high blood sugar levels. It often develops in adults and can cause symptoms like increased thirst, frequent urination, and fatigue.
Chronic Kidney Disease (CKD) is a long-term condition where the kidneys do not work effectively, leading to a gradual loss of kidney function. Symptoms may include fatigue, swelling in the legs, and changes in urination.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.